Tag Archives: GSK in Asia

The global pharmaceutical landscape is changing. Big pharma companies are merging and getting bigger in order to expand their pipelines, and they are getting leaner, shedding jobs in the most expensive markets. The future of big pharma, everyone seems to think, is in low-cost Asia. I recently talked to a big pharma exec who seems to think otherwise. While he acknowledges that the industry is undergoing changes and increasingly moving East, he also talks of it being a process that is much more akin to an equilibrium process than a one way plane route.